Cargando…
Microalbuminuria and cardiorenal risk: old and new evidence in different populations
Since the association of microalbuminuria (MAU) with cardiovascular (CV) risk was described, a huge number of reports have emerged. MAU is a specific integrated marker of CV risk and targets organ damage in patients with hypertension, chronic kidney disease (CKD), and diabetes and its recognition is...
Autores principales: | Márquez, Diego Francisco, Ruiz-Hurtado, Gema, Segura, Julian, Ruilope, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758838/ https://www.ncbi.nlm.nih.gov/pubmed/31583081 http://dx.doi.org/10.12688/f1000research.17212.1 |
Ejemplares similares
-
TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension
por: Santiago-Hernandez, Aranzazu, et al.
Publicado: (2021) -
Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets
por: Navarro-García, José Alberto, et al.
Publicado: (2021) -
The impact of antihypertensives on kidney disease
por: Marquez, Diego F, et al.
Publicado: (2017) -
Editorial: Contribution of Uremic Compounds to Cardiorenal Syndrome Development
por: Carneiro-Ramos, Marcela Sorelli, et al.
Publicado: (2022) -
Cardiovascular and Renal Links along the Cardiorenal Continuum
por: García-Donaire, José A., et al.
Publicado: (2011)